Core Points - The company has adjusted the maximum repurchase price from RMB 42 per share to RMB 50 per share, which is not more than 150% of the average stock price over the last 30 trading days prior to the decision [1][2] - Other aspects of the repurchase plan remain unchanged, and the adjustment does not require shareholder approval [1][3] Repurchase Plan Overview - The company approved a share repurchase plan on August 8, 2024, with a total repurchase amount between RMB 30 million and RMB 60 million, and a repurchase period of 12 months [1][2] - As of now, the company has repurchased 248,500 shares, accounting for 0.39% of the total share capital, with a total expenditure of approximately RMB 9.78 million [2] Impact of Price Adjustment - The adjustment of the repurchase price is intended to facilitate the smooth implementation of the repurchase plan and to protect the company's value and shareholder interests [2][3] - The estimated additional repurchase quantity ranges from 652,900 to 1,252,900 shares, representing approximately 1.02% to 1.96% of the total share capital [3] Decision-Making Process - The adjustment was approved by the company's fourth board of directors' twelfth meeting and does not require further shareholder approval [3]
百合股份: 威海百合生物技术股份有限公司关于调整回购股份价格上限的公告